The Ritedose Corporation FDA Inspection Record
The Ritedose Corporation is an FDA-registered facility (FEI 3001237796) located in Columbia, SC, US. Registered operations: ANALYSIS. RegDataLab tracks 12 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Feb 28, 2025: Voluntary Action Indicated (VAI)
- Inspections on record
- 12 (5 VAI, 7 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Form 483 and inspection documents
- 1 in FDA's reading room
- Recalls as the recalling firm
- 4, latest Oct 15, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 28, 2025 | Voluntary Action Indicated (VAI) | Defined areas of adequate size for operations (21 CFR 211.42(c)) Validation lacking for sterile drug products (21 CFR 211.113(b)) Investigations of discrepancies, failures (21 CFR 211.192) |
| Mar 22, 2022 | Voluntary Action Indicated (VAI) | Investigations of discrepancies, failures (21 CFR 211.192) |
| Apr 18, 2019 | No Action Indicated (NAI) | No citations listed |
| Mar 3, 2017 | Voluntary Action Indicated (VAI) | Following/documenting laboratory controls (21 CFR 211.160(a)) Design history file (21 CFR 820.30(j)) Management review - Lack of or inadequate procedures (21 CFR 820.20(c)) Documentation (21 CFR 820.100(b)) and 1 more |
| Jul 31, 2015 | Voluntary Action Indicated (VAI) | No citations listed |
| Apr 17, 2014 | No Action Indicated (NAI) | No citations listed |
| Nov 8, 2012 | No Action Indicated (NAI) | No citations listed |
| Sep 9, 2011 | No Action Indicated (NAI) | No citations listed |
| Jan 6, 2011 | Voluntary Action Indicated (VAI) | No citations listed |
| Sep 30, 2010 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 15, 2026 | Class II | D-0073-2027 | Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually… Failed Impurities/Degradation Specification |
| Jul 21, 2023 | Class II | D-0946-2023 | Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx… CGMP deviation: product released prior to supplier approval. |
| Apr 1, 2022 | Class III | D-0745-2022 | 23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx… Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of… |
| Dec 23, 2010 | Class I | D-281-2011 | Albuterol Sulfate Inhalation Solution, 0.083% , 2.5 mg/3 mL, Supplied in 25, 30, and 60 x… The Product is Misbranded: The concentration of the product is 2.5 mg/3 mL; however, the embossing on the single use vials states 0.5 mg/3… |
Form 483s and inspection documents
FDA record score
18 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
8 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Feb 28, 2025 | 6 x 1 | 6 |
| Class II recall D-0073-2027, this FEI as the recalling firm | Oct 15, 2026 | 4 x 1 | 4 |
| Inspection classified VAI | Mar 22, 2022 | 6 x 0.6 | 3.6 |
| Class II recall D-0946-2023, this FEI as the recalling firm | Jul 21, 2023 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Mar 3, 2017 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Jul 31, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 6, 2011 | 10 years or older, so it adds no points | 0 |
| Class I recall D-281-2011, this FEI as the recalling firm | Dec 23, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing The Ritedose Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check The Ritedose Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- The Ritedose Corporation
- Location
- Columbia, SC (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS
- Source
- both